Xanthine Oxidoreductase Is Involved in Chondrocyte Mineralization and Expressed in Osteoarthritic Damaged Cartilage. [PDF]
Nasi S +9 more
europepmc +1 more source
HepG2 cells do not express xanthine oxidoreductase (XOR): Implications for XOR and uric acid-related research. [PDF]
King RD +5 more
europepmc +1 more source
Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice. [PDF]
Nakamura T +6 more
europepmc +1 more source
Cardiovascular Events During Treatment With Xanthine Oxidoreductase Inhibitors in Patients With Gout and Hyperuricemia in Japan - A JMDC Claims Database Study. [PDF]
Kario K, Akari S, Kanegae H.
europepmc +1 more source
Allopurinol, Febuxostat, and Nonuse of Xanthine Oxidoreductase Inhibitor Treatment in Patients Receiving Hemodialysis: A Longitudinal Analysis. [PDF]
Ishii T +5 more
europepmc +1 more source
Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity in patients with type 2 diabetes. [PDF]
Kitamura A +9 more
europepmc +1 more source
The nitrite reductase activity of xanthine oxidoreductase sustains cardiovascular health
Dyson N +14 more
europepmc +1 more source
Xanthine Oxidoreductase Inhibitors
Xanthine oxidase inhibitors are primarily used in the clinical prevention and treatment of gout associated with hyperuricemia. The archetypal xanthine oxidase inhibitor, Allopurinol has been shown to have other beneficial effects such as a reduction in vascular reactive oxygen species and mechano-energetic uncoupling.
Jacob George, Keeran Vickneson
exaly +5 more sources
Related searches:
Physiological Roles of Xanthine Oxidoreductase
Drug Metabolism Reviews, 2004Xanthine oxidoreductase (XOR) is a major protein component of the milk fat globule membrane (MFGM) surrounding fat droplets in milk and its enzymology is well characterised. The enzyme is widely distributed in mammalian tissues and is generally accepted to be a key enzyme of purine catabolism.
Roger Harrison
exaly +3 more sources

